Lip Augmentation Market Research Report – Forecast till 2027

Lip Augmentation Market Research Report: By Type (Temporary and Permanent Lip Augmentation), Lip Fillers (Fat Injection or Lipoinjection, Hyaluronic Acid Fillers, Lip Collagen Injections & Others), Distribution Channel - Forecast Till 2027

ID: MRFR/HC/5762-HCR | February 2021 | Region: Global | 90 pages

Lip Augmentation Market Scenario


Lip Augmentation Market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 10.5% over the forecast period. 


Lip augmentation is a cosmetic procedure which is used to get fuller and plumper lips. Hyaluronic acid based-dermal fillers are mostly preferred for lip augmentation.


Rising participation of market players and development of medical tourism industry are the prominent factors driving the lip augmentation market. For instance, in 2018, Allergan plc launched a new JUVÉDERM advertising campaign created to empower the next generation of consumers to "JUVÉDERM IT." The JUVÉDERM collection of fillers offers a complete range of dermal fillers for different patient needs. JUVÉDERM Ultra XC is used into the lips and perioral area for lip augmentation in adults over 21. Moreover, in 2017, Allergan plc acquired LifeCell Corporation, a leading regenerative medicine company, for approximately USD 2.9 billion in cash.


Various other factors such as increasing awareness about lip augmenation, rising geriatric population and rising demand for dermal fillers are also expected to propel the growth of the market.


However, side effects associated with lip fillers and high cost of treatment can hamper the market growth over the forecast period.


Segmentation


The lip augmentation market is segmented based on type, lip fillers, distribution channel, and region.


The global market for lip augmentation, by type is segmented into temporary lip augmentation and permanent lip augmentation. The permanent lip augmentation segment is further classified as dermal graft, permanent lip implants, vermilion lip advancement and lip lift. The lip lift segment includes corner lip lift and upper lip lift.


The market, by lip fillers, is segmented into fat injection or lipoinjection, hyaluronic acid fillers, lip collagen injections, platelet-rich plasma (PRP), and others.


Based on distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies, drug stores, online pharmacies, and others.


The hospital pharmacies segment is anticipated to hold the largest market share owing to the increasing demand for cosmetic procedures. The online pharmacies are expected to grow at the highest CAGR owing to the rising cases of cosmetic problems.


In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.


The lip augmentation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European lip augmentation market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The lip augmentation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The lip augmentation market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Lip Augmentation market Share (%), by Region, 2017



Sources: MRFR Analysis


The Americas dominated the global market for lip augmentation owing to the rising geriatric population. According to the Population Reference Bureau report, the number of Americans ages 65 and older is projected to double from 46 million today to over 98 million by 2060. Moreover, rising healthcare spending within the region is also boosting the lip augmentation market. In the US, the total healthcare spending reached USD 3.5 trillion in 2017 and by 2026; it is expected to reach USD 5.7 trillion.


In 2017, it was estimated that Europe stood second in the global lip augmentation market. This can be attributed to the rising research and development investments and technological advancements. For instance, in 2017, Allergan received FDA approval for its newest hyaluronic acid dermal filler, Juvéderm Vollure XC.


Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing medical tourism industry and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region.


On the other hand, the Middle East and Africa held least share in the global lip augmentation market due to the low per capita income, especially within the African region.


Key players


Some of the key players in the lip augmentation market are Allergan, Galderma Pharma S.A., Integra Lifesciences, Laboratories Vivacy SAS, Merz Pharma, Sinclair Pharma, Suneva Medical, Inc, Teoxane, Cynosure, Syneron, AQTIS Medical, Bioha Laboratories, Cytophil, Inc., Dr. Korman Laboratories, Inamed Corporation, and Anika Therapeutics Inc., and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the lip augmentation. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


Intended Audience



  • Pharmaceutical Companies

  • Government and Private Laboratories

  • Research and Development (R&D) companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Market Segmentation and Key Market Players


Lip Augmentation Market, by Type



  • Temporary Lip Augmentation

  • Permanent Lip Augmentation

    • Dermal Graft

    • Permanent Lip Implants

    • Vermilion Lip Advancement

    • Lip Lift

      • Corner Lip Lift

      • Upper Lip Lift






Lip Augmentation Market, by Lip Fillers



  • Fat Injection or Lipoinjection

  • Hyaluronic Acid Fillers

  • Lip Collagen Injections

  • Platelet-rich Plasma (PRP)

  • Others


Lip Augmentation Market, by Distribution Channel



  • Hospital Pharmacies

  • Clinics 

  • Retail Pharmacies 

  • Drug Stores

  • Online Pharmacies

  • Others 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   10.5% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Lip fillers, Distribution channel
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Allergan, Galderma Pharma S.A., Integra Lifesciences, Laboratories Vivacy SAS, Merz Pharma, Sinclair Pharma, Suneva Medical, Inc, Teoxane, Cynosure, Syneron, AQTIS Medical, Bioha Laboratories, Cytophil, Inc., Dr. Korman Laboratories, Inamed Corporation, and Anika Therapeutics Inc., and others
  Key Market Opportunities

  • Increasing awareness about lip augmenation
  • Rising geriatric population
  • Rising demand for dermal fillers
  •   Key Market Drivers

  • Rising participation of market players
  • Development of medical tourism industry


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Lip Augmentation Market would grow with a 10.5% CAGR during the forecast period of 2018 to 2023.

    High cost and side-effects could prevent the Lip Augmentation Market growth.

    Lip Augmentation Market has distribution channels like clinics, hospital pharmacies, drug stores, online pharmacies, retail pharmacies, and others.

    Lip Augmentation Market has lip fillers like hyaluronic acid fillers, fat injection or lipo injection, platelet-rich plasma (PRP), lip collagen injections, and others.

    Americas would dominate the Lip Augmentation Market.

    Table of Contents:


    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Macroeconomic Indicators

    4.5 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    Chapter 6. Global Lip Augmentation Market, by Type

    6.1 Introduction

    6.2 Temporary Lip Augmentation

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Permanent Lip Augmentation

    6.3.1 Dermal Graft

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.2 Permanent Lip Implants

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.3 Vermilion Lip Advancement

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.4 Lip Lift

    6.3.4.1 Corner Lip Lift

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3.4.2 Upper Lip Lift

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Lip Augmentation Market, by Lip Fillers

    7.1 Introduction

    7.2 Fat Injection or Lipoinjection

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Hyaluronic Acid Fillers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Lip Collagen Injections

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 Platelet-rich Plasma (PRP)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.6 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Lip Augmentation Market, by Distribution Channel

    8.1 Introduction

    8.2 Hospital Pharmacies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Retail Pharmacies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Drug Stores

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.6 Online Pharmacies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.7 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Lip Augmentation Market, by Region

    9.1 Introduction

    9.2 Americas

    9.2.1 North America

    9.2.1.1 U.S.

    9.2.1.2 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia-Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 South Korea

    9.4.6 Rest of Asia-Pacific

    9.5 Middle East & Africa

    9.5.1 Middle East

    9.5.2 Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    Chapter 11. Company Profiles

    11.1 Allergan

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials Overview

    11.1.4 Key Developments

    11.1.5 SWOT Analysis

    11.2 Galderma Pharma S.A.

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 Integra Lifesciences

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Laboratoire Vivacy SAS

    11.4.1 Company Overview

    11.4.2 Product Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Inamed Corporation

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Merz Pharma

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 Sinclair Pharma

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financial Overview

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Suneva Medical, Inc

    11.8.1 Overview

    11.8.2 Product Overview

    11.8.3 Financials

    11.8.4 Key Developments

    11.8.5 SWOT Analysis

    11.9 Teoxane

    11.9.1 Overview

    11.9.2 Product Overview

    11.9.3 Financials

    11.9.4 Key Developments

    11.9.5 SWOT Analysis

    11.10 Cynosure

    11.10.1 Overview

    11.10.2 Product Overview

    11.10.3 Financials

    11.10.4 Key Developments

    11.10.5 SWOT Analysis

    11.11 Syneron

    11.11.1 Overview

    11.11.2 Product Overview

    11.11.3 Financials

    11.11.4 Key Developments

    11.11.5 SWOT Analysis

    11.12 AQTIS Medical

    11.12.1 Overview

    11.12.2 Product Overview

    11.12.3 Financials

    11.12.4 Key Developments

    11.12.5 SWOT Analysis

    11.13 Bioha Laboratories

    11.13.1 Overview

    11.13.2 Product Overview

    11.13.3 Financials

    11.13.4 Key Developments

    11.13.5 SWOT Analysis

    11.14 Cytophil, Inc.

    11.14.1 Overview

    11.14.2 Product Overview

    11.14.3 Financials

    11.14.4 Key Developments

    11.14.5 SWOT Analysis

    11.15 Dr. Korman Laboratories

    11.15.1 Overview

    11.15.2 Product Overview

    11.15.3 Financials

    11.15.4 Key Developments

    11.15.5 SWOT Analysis

    11.16 Other

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s Viewpoint

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Predictionsfor the global lip augmentation market

    Chapter 13. Appendix

    LIST OF TABLES

    Table 1 Lip Augmentation Market Synopsis, 2020-2027

    Table 2 Lip Augmentation Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Lip Augmentation Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 5 Global Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 6 Global Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

    Table 7 North America: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 8 North America: Lip Augmentation Market, by Lip Fillers, 2020-2027(USD Million)

    Table 9 North America: Lip Augmentation Market, Distribution Channel, 2020-2027 (USDMillion)

    Table 10 US: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 11 US: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 12 US: Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

    Table 13 Canada:Lip Augmentation Market,byType, 2020-2027 (USD Million)

    Table 14 Canada: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 15 Canada: Lip Augmentation Market, Distribution Channel, 2020-2027 (USDMillion)

    Table 16 South America: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 17 South America: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 18 South America: Lip Augmentation Market, Distribution Channel, 2020-2027 (USDMillion)

    Table 19 Europe: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 20 Europe: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 21 Europe: Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

    Table 22 Western Europe: Lip Augmentation Market, by Type, 2020-2027 (USDMillion)

    Table 23 Western Europe: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 24 Western Europe: Lip Augmentation Market, by Distribution Channel, 2020-2027(USD Million)

    Table 25 Eastern Europe: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 26 Eastern Europe: Lip Augmentation Market, by Lip Fillers, 2020-2027 (USD Million)

    Table 27 Eastern Europe: Lip Augmentation Market, Distribution Channel, 2020-2027(USD Million)

    Table 28 Asia-Pacific: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 29 Asia-Pacific: Lip Augmentation Market,by Lip Fillers, 2020-2027 (USD Million)

    Table 30 Asia-Pacific: Lip Augmentation Market, Distribution Channel, 2020-2027 (USD Million)

    Table 31 Middle East & Africa: Lip Augmentation Market, by Type, 2020-2027 (USD Million)

    Table 32 Middle East & Africa: Lip Augmentation Market, by Lip Fillers,2020-2027 (USD Million)

    Table 33 Middle East & Africa: Lip Augmentation Market, Distribution Channel, 2020-2027(USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Lip Augmentation Market

    Figure 3 Market Dynamics for Global Lip Augmentation Market

    Figure 4 Lip Augmentation Market Share, by Type,2020

    Figure 5 Lip Augmentation Market Share, by Lip Fillers,2020

    Figure 6 Lip Augmentation Market Share, Distribution Channel, 2020

    Figure 7 Lip Augmentation Market Share, by Region, 2020

    Figure 8 North America: Lip Augmentation Market Share, by Country, 2020

    Figure 9 Europe: Lip Augmentation Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Lip Augmentation Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Lip Augmentation Market Share, by Region, 2020

    Figure 12 Lip Augmentation Market : Company Share Analysis, 2020 (%)

    Figure 13 Allergan: Key Financials

    Figure 14 Allergan: Segmental Revenue

    Figure 15 Allergan: Geographical Revenue

    Figure 16 Galderma Pharma S.A. : Key Financials

    Figure 17 Galderma Pharma S.A. : Segmental Revenue

    Figure 18 Galderma Pharma S.A. : Geographical Revenue

    Figure 19 Integra Lifesciences:Key Financials

    Figure 20 Integra Lifesciences: Segmental Revenue

    Figure 21 Integra Lifesciences: Geographical Revenue

    Figure 22 Laboratoire Vivacy SAS: Key Financials

    Figure 23 Laboratoire Vivacy SAS: Segmental Revenue

    Figure 24 Laboratoire Vivacy SAS: Geographical Revenue

    Figure 25 Inamed Corporation:Key Financials

    Figure 26 Inamed Corporation: Segmental Revenue

    Figure 27 Inamed Corporation: Geographical Revenue

    Figure 28 Merz Pharma: Key Financials

    Figure 29 Merz Pharma: Segmental Revenue

    Figure 30 Merz Pharma: Geographical Revenue

    Figure 31 Sinclair Pharma: Key Financials

    Figure 32 Sinclair Pharma: Segmental Revenue

    Figure 33 Sinclair Pharma: Geographical Revenue

    Figure 34 Suneva Medical, Inc:Key Financials

    Figure 35 Suneva Medical, Inc: Segmental Revenue

    Figure 36 Suneva Medical, Inc: Geographical Revenue

    Figure 37 Teoxane: Key Financials

    Figure 38 Teoxane: Segmental Revenue

    Figure 39 Teoxane: Geographical Revenue

    Figure 40 Cynosure: Key Financials

    Figure 41 Cynosure: Segmental Revenue

    Figure 42 Cynosure: Geographical Revenue

    Figure 43 Syneron : Key Financials

    Figure 44 Syneron :Segmental Revenue

    Figure 45 Syneron : Geographical Revenue

    Figure 46 AQTIS Medical: Key Financials

    Figure 47 AQTIS Medical: Segmental Revenue

    Figure 48 AQTIS Medical: Geographical Revenue

    Figure 49 Bioha Laboratories: Key Financials

    Figure 50 Bioha Laboratories: Segmental Revenue

    Figure 51 Bioha Laboratories: Geographical Revenue

    Figure 52 Cytophil, Inc.: Key Financials

    Figure 53 Cytophil, Inc.: Segmental Revenue

    Figure 54 Cytophil, Inc.: Geographical Revenue

    Figure 55 Dr. Korman Laboratories: Key Financials

    Figure 56 Dr. Korman Laboratories: Segmental Revenue

    Figure 57 Dr. Korman Laboratories: Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.